Cheng et al. found that fenofibrate prevents the development of diabetic nephropathy in mice with type 1 diabetes via upregulating FGF21 and stimulating PI3K/Akt/GSK-3β/Fyn-mediated activation of the Nrf2 pathway [10]. The gene discussed is FGF21; the disease is diabetic kidney disease.